Details of the Drug

General Information of Drug (ID: DMFY63O)

Drug Name

Posoleucel

Synonyms

ALVR105

Indication

Disease Entry	ICD 11	Status	REF
Hemorrhagic cystitis	GC00.1	Phase 3	[1]
------------------------------------------------------------------------------------

Drug Type

Cell therapy

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04390113) Phase 3 Multicenter, Double-Blind, Placebo-Controlled Trial of Viralym-M (ALVR105) for the Treatment of Patients With Virus-Associated Hemorrhagic Cystitis After Allogeneic Hematopoietic Cell Transplant (HCT). U.S.National Institutes of Health.